COMMUNIQUÉS West-GlobeNewswire

ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call
17/07/2018
SAN CLEMENTE, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors
17/07/2018
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund
17/07/2018
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that it has signed an Intellectual Property [...]
CytomX Therapeutics Announces Closing of Public Offering of Common Stock
17/07/2018
SOUTH SAN FRANCISCO, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Orion Biotechnology Awarded a $2M Grant from National Center for Research and Development to Fund Further Development of its HIV Microbicide
17/07/2018
OTTAWA, July 17, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its European subsidiary, Orion Biotechnology Polska Sp. z o.o., was awarded a [...]
bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung
17/07/2018
SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an advanced flow [...]
Tabula Rasa HealthCare Hosts Inaugural PACE Executive Director Advisory Meeting
17/07/2018
Goal: to confirm client priorities and perspectives related to future healthcare and changes for PACE MOORESTOWN, N.J., July 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC) held its annual [...]
Matrix Medical Network announces the appointment of Ian Worden as Vice President, Product & Marketing
17/07/2018
SCOTTSDALE, Ariz., July 17, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix), a leading population health provider of in-home and mobile health services, has announced that Ian Worden has joined the company as [...]
K2M Enhances CASCADIA™ Lateral 3D Interbody System Featuring Lamellar 3D Titanium Technology™ Following Clearances for CAYMAN® United Plate System
17/07/2018
3D-printed lateral cage becomes the first-ever 3D surgical solution with modular fixation capabilities LEESBURG, Va., July 17, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a [...]
Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018
17/07/2018
MIAMI, July 17, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of [...]
electroCore and UpScript Launch Program to Offer Direct-to-Patient Telemedicine Option for gammaCore™ in the United States
17/07/2018
BASKING RIDGE, N.J., July 17, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, announced today a program with UpScript, a digital healthcare platform, offering [...]
Cellectar Reports 94% Reduction in Overall Tumor Volume in Waldenstrom Macroglobulinemia Patient in Phase 2 CLR 131 Clinical Study
17/07/2018
MADISON, Wis., July 17, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
Avadel Pharmaceuticals to Report Second Quarter 2018 Results
17/07/2018
DUBLIN, Ireland, July 17, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), today announced it will report its second quarter 2018 financial results on Tuesday, August 7, 2018, before the market open. A [...]
Parkinson’s Disease Pathogenesis may have a Bacterial Virus Component According to Research Conducted by Human Microbiology Institute
17/07/2018
Full study data published in Scientific Reports NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Human Microbiology Institute (HMI), a not-for-profit scientific research organization, and Tetz Laboratories today announced [...]
Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form
17/07/2018
BEVERLY, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a Drug Product [...]
Eloxx Pharmaceuticals To Report Second Quarter 2018 Financial Results On August 7, 2018 and Host Webcast and Conference Call
17/07/2018
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
VitalHub Announces First Municipal Client Sale for VH LTC Solution
17/07/2018
TORONTO, July 17, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased to announce the sale of VH LTC solution to the Seniors’ Services division of the Region of Waterloo, marking [...]
The Lefebvre Foundation: Man taking seven million steps for cancer will walk from North Bay to Quebec in coming weeks
17/07/2018
NORTH BAY, Ontario, July 17, 2018 (GLOBE NEWSWIRE) -- When Jimmy Lefebvre lost his father to cancer he couldn’t accept how his father was forced to quickly succumb to the disease. Lefebvre is now over half-way across [...]
Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinson’s Disease and Provides Clinical Update
17/07/2018
Voyager continues to plan to submit a BLA for VY-AADC based on its pivotal program and Type C meeting feedback Positive interim results with VY-AADC from the Phase 1 posterior trajectory trial supports the surgical [...]

Pages